SlideShare uma empresa Scribd logo
1 de 18
Group 9
Group 9
 Puveraj Gunasekaran 130110132026
 Nor Adira Eliany Binti Alias 130110113053
 Michelle Ann Sheridan Daniel 130110132017
 Visalakshi Ramanathan 130110132042
 Muhammad Ikhlas Abdian Putra 130110130126
 Raka Ghufran Wibowo 130110130170
 Ahsani Rahma Rudibianti 130110130073
 Muhammad Nuur Fauzi 130110130049
 Renita Dewi Supiyana 130110130115
 Amalia Ahsani 130110130061
 Evi Anugrah Arumningsih 130110130074
 Fatimah Amalia 130110130140
 Nabila Nauli Asriputri 130110130155
 Jasmine Maulinda Utami 130110130195
Answerable question based on the scenario
above according to PICO scheme.
 Patient or problem : 60-year old female
newly diagnosed with peripheral arterial
disease
 Intervention : type 2 diabetes
 Comparison : -
 Outcome : peripheral arterial disease.
Critical Appraisal based on Tool
Kit
1. Did the study address a clearly
focused issue?
 Yes, The population studied were clearly
described and the risk factors were also
mentioned. Besides that, the outcomes
were considered in two ways where there
was a primary outcome and a secondary
outcome. It’s clear that the study tried to
detect a beneficial effect.
Critical Appraisal based on Tool
Kit
2. Did the authors use an appropriate method to
answer their question?
 Is a cohort study a good way of answering the
question under the circumstances? Yes
 Did it address the study question? We have
addressed these gaps in knowledge by establishing
a large prospective cohort using linked electronic
health records,8,9 which combine information about
diabetes diagnosis, risk factors, and medication use
with future cardiovascular events. Our objective was
to investigate and compare associations between
type 2 diabetes and future risk of 12 of the most
common initial cardiovascular presentations in men
and women.
Critical Appraisal based on Tool
Kit
3. Were the cohort recruited in an acceptable way?
 No, because not all subjects are classified into expose
group using the same procedure this study used
multivariable cox regression they also used multiple
imputation to account missing covariate data
Critical Appraisal based on Tool
Kit
4. Was the exposure accurately measured to minimize bias?
Yes
HINT: We are looking for measurement or classification bias:
- Did they use subjective or objective measurements?
Objective. We defined individuals as having diabetes at
baseline (type 1, type 2, or uncertain type) on the basis of
coded diagnoses recorded in CPRD or hospital episode
statistics at or before study entry (appendix).
- Do the measures truly reflect what you want them to (have
they been validated)? : Cant tell.
- Were all the subjects classified into exposure groups using
the same procedure? : Yes
We defined individuals as having diabetes at baseline (type
1, type 2, or uncertain type) on the basis of coded diagnoses
recorded in CPRD or hospital episode statistics at or before
study entry (appendix).
Critical Appraisal based on Tool
Kit5. Was the outcome accurately measured to minimize bias?
 Yes
- Did they use subjective or objective measurements? objective
measurement
- Do the measures truly reflect what you want them to (have they been
validated)? they have been validated
- Has a reliable system been established for detecting all the cases
(for measuring disease occurrence)? reliable system has been
established for detecting all the case
- Were the measurement methods similar in the different groups?
measurement were similar in different group
- Were the subjects and/or the outcome assessor blinded to exposure
(does this matter)? no blinded to exposure
Critical Appraisal based on Tool
Kit
6. A. Have the authors identified all important confounding factors?
Yes
List the ones you think might be important, that the authors missed.
B. Have they taken account of the confounding factors in the design
and/or analysis? Yes
 Modeling :
Social deprivation was included in models as quintiles of the index of
multiple deprivation, a score calculated for each participant’s
neighbourhood on the basis of social indices such as income, education,
and employment
 Stratified :
Data recorded before study entry were used to classify participants as
never smokers, ex-smokers, or current smokers at baseline. The baseline
hazard function of each model was stratifi ed by general practice and sex,
and we used multiple imputation to account for missing covariate data
(appendix). We also did analyses adjusted for age and sex only, and
analyses adjusted for age, sex, and cardiovascular risk factors. We
assessed interactions with age and sex.
Critical Appraisal based on Tool
Kit
 Regression :
We used multivariable Cox regression to calculate cause-
specific hazards for associations between type 2 diabetes
and initial presentations of cardiovascular disease.
 Sensitivity :
We did a sensitivity analysis comparing individuals with any
diabetes diagnosis to those without diabetes (most patients
with diabetes in a cohort of this age would have type 2
diabetes). We did sensitivity analyses ignoring endpoints
recorded only in primary care (CPRD), restricted to fatal
endpoints, or restricted to individuals who entered the study
after 2004. We did analyses using R 2.15. This trial is
registered with ClinicalTrials.gov, number NCT01804439.
Critical Appraisal based on Tool
Kit
7. A. Was the follow up of subjects
complete enough? Yes
B. Was the follow up of subjects long
enough? Yes
Because the long of the interval is 5,5
years
Critical Appraisal based on Tool
Kit
8. What are the results of this study?
-This study includes 1921260 individuals whereby
1887062 did not have diabetes and 34198 had DM Type
2.
-There were 113638 cardiovascular events over
11.6million person-years of follow up.
-6137 were DM Type 2 individuals, where 992 individual
with peripheral arterial disease and 866 individual with
heart failure was the first presentation.
-107501 were individual without DM Type 2, where 10074
with peripheral arterial disease and 13072 individual with
heart failure was the first presentation.
Critical Appraisal based on Tool
Kit
-For individual aged 40 years without cardiovascular disease,
risk of getting CD by 80years old :-
-No other statistically significant differences between sexes.
-In DM Type2 individual, risk of cardiovascular disease was
highest for those with HbA1c concentration of 58 mmol/mol or
higher.
-Individual with DM Type2 and HbA1c concentration less than
48mmol/mol had an increased risk of peripheral arterial disease
and ischaemic stroke, but no greater risk of any of the other 12
cardiovascular diseases.
Critical Appraisal based on Tool
Kit
9. How precise are the results?
 How precise is the estimate of the risk?
By looking at the value of confidence interval
HINT:
- Size of the confidence intervals
The prevalence of any type of diabetes in all
individuals in CALIBER aged 40–50 years (with
or without previous cardiovascular disease) was
1·52% (95% CI 1·47–1·57) in women and 2·25%
(2·19–2·32) in men (appendix).
Critical Appraisal based on Tool
Kit
10. Do you believe the results?
 HINT:
-Big effect is hard to ignore! (???)
-Can it be due to bias, chance or confounding? No
-Are the design and methods of this study sufficiently flawed to make the
results unreliable? No. This study used records from the CALIBER
programme, which links data for people in England recorded in four
electronic health data sources. They define individuals as having diabetes
using CPRD record and also check the HbA measurements for diabetic
patients. And also they use cumulative incidence curves for comparing the
initial presentation of cardiovascular disease and used Cox models to
estimate cause-specific hazard ratios. And overall, the result were robust to
a range of modifications explored in sensitivity analyses, which is type 2
diabetes was strongly associated with composite cardiovascular mortality
and all-cause mortality.
-Consider Bradford-Hills criteria!
Critical Appraisal based on Tool
Kit
 11. Can the results be applied to the local population? YES
 HINT:
consider whether:
1. the subjects covered in the study could be sufficiently different
from your population to cause concern
2. your local setting is likely to differ much from that of the study
3. can you quantify local benefit and harm?
benefit: because this research take subjects from wide range of
population in UK, obviously it can represent local population there.
so, the benefit for local people are they can prevent cardiovascular
disease if they have DM type 2
harm: wide range of cardiovascular disease that might occur could
confusing us, it could lead us to wrong preventive action with
harmful effect.
Critical Appraisal based on Tool
Kit
 12. Do the results of this study fit
with other available evidence? Yes
Thank You

Mais conteúdo relacionado

Mais procurados

Cross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek KumarCross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek Kumar
ak07mail
 
Lecture 5 case control & cross-sectional spring 2013
Lecture 5  case control & cross-sectional spring 2013Lecture 5  case control & cross-sectional spring 2013
Lecture 5 case control & cross-sectional spring 2013
maythayel
 
Malimu cross sectional studies.
Malimu cross sectional studies.Malimu cross sectional studies.
Malimu cross sectional studies.
Miharbi Ignasm
 

Mais procurados (20)

Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Cross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek KumarCross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek Kumar
 
Lecture 5 case control & cross-sectional spring 2013
Lecture 5  case control & cross-sectional spring 2013Lecture 5  case control & cross-sectional spring 2013
Lecture 5 case control & cross-sectional spring 2013
 
Cross sec study dr rahul
Cross sec study dr rahulCross sec study dr rahul
Cross sec study dr rahul
 
7-Cohort Studies
7-Cohort Studies7-Cohort Studies
7-Cohort Studies
 
Descriptive epidemiology
Descriptive epidemiologyDescriptive epidemiology
Descriptive epidemiology
 
Steps in cohort study
Steps in cohort studySteps in cohort study
Steps in cohort study
 
cohort study
cohort studycohort study
cohort study
 
Cohort studies..NIKHNA JAYAN
Cohort studies..NIKHNA JAYANCohort studies..NIKHNA JAYAN
Cohort studies..NIKHNA JAYAN
 
Nested case control study
Nested case control studyNested case control study
Nested case control study
 
cohort study
cohort studycohort study
cohort study
 
Research Methodology - Case control study
Research Methodology - Case control studyResearch Methodology - Case control study
Research Methodology - Case control study
 
Cross sectional studies
Cross sectional studiesCross sectional studies
Cross sectional studies
 
Cohort ppt
Cohort pptCohort ppt
Cohort ppt
 
Malimu cross sectional studies.
Malimu cross sectional studies.Malimu cross sectional studies.
Malimu cross sectional studies.
 
Cohort study
Cohort studyCohort study
Cohort study
 
SAMS EBM Online Course: Observational Study Designs
SAMS EBM Online Course: Observational Study DesignsSAMS EBM Online Course: Observational Study Designs
SAMS EBM Online Course: Observational Study Designs
 
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
Observational analytical study:  Cross-sectional, Case-control and Cohort stu...Observational analytical study:  Cross-sectional, Case-control and Cohort stu...
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
 
5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
 
Case Control Study Design
Case Control Study DesignCase Control Study Design
Case Control Study Design
 

Destaque

Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2
RobHeerdink
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
Bhumika Bhatt
 

Destaque (12)

Farmacoepi Course Leiden 0210 Part 2
Farmacoepi Course Leiden 0210   Part 2Farmacoepi Course Leiden 0210   Part 2
Farmacoepi Course Leiden 0210 Part 2
 
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
2 Research and Impact Lessons from Young Lives Cohort Study, Paul Dornan
 
Measurement risk and the impact on your processes
Measurement risk and the impact on your processes  Measurement risk and the impact on your processes
Measurement risk and the impact on your processes
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
 
Cohort Study
Cohort StudyCohort Study
Cohort Study
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
 
How to stand out online
How to stand out onlineHow to stand out online
How to stand out online
 
2012 and We're STILL Using PowerPoint Wrong
2012 and We're STILL Using PowerPoint Wrong2012 and We're STILL Using PowerPoint Wrong
2012 and We're STILL Using PowerPoint Wrong
 
Your Speech is Toxic
Your Speech is ToxicYour Speech is Toxic
Your Speech is Toxic
 
Great Speakers Tell Stories
Great Speakers Tell StoriesGreat Speakers Tell Stories
Great Speakers Tell Stories
 
Slides That Rock
Slides That RockSlides That Rock
Slides That Rock
 
SMOKE - The Convenient Truth [1st place Worlds Best Presentation Contest] by ...
SMOKE - The Convenient Truth [1st place Worlds Best Presentation Contest] by ...SMOKE - The Convenient Truth [1st place Worlds Best Presentation Contest] by ...
SMOKE - The Convenient Truth [1st place Worlds Best Presentation Contest] by ...
 

Semelhante a Crp critical appraisal group 9 cohort

RunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docxRunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docx
rtodd599
 
Mild cognitive impairment
Mild cognitive impairmentMild cognitive impairment
Mild cognitive impairment
carlafig
 
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docxRunning Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
glendar3
 
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docxRunning Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
todd581
 
Relationship Between Obesity Diabetes PICOT Essay.pdf
Relationship Between Obesity Diabetes PICOT Essay.pdfRelationship Between Obesity Diabetes PICOT Essay.pdf
Relationship Between Obesity Diabetes PICOT Essay.pdf
4934bk
 
TYPE 2 DIABETES TYPE 2 DIABETES .docx
TYPE 2 DIABETES TYPE 2 DIABETES                               .docxTYPE 2 DIABETES TYPE 2 DIABETES                               .docx
TYPE 2 DIABETES TYPE 2 DIABETES .docx
marilucorr
 
Articulo 1
Articulo 1Articulo 1
Articulo 1
rcm1990
 

Semelhante a Crp critical appraisal group 9 cohort (20)

RunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docxRunningHead PICOT Question1RunningHead PICOT Question7.docx
RunningHead PICOT Question1RunningHead PICOT Question7.docx
 
1.1
1.11.1
1.1
 
Mild cognitive impairment
Mild cognitive impairmentMild cognitive impairment
Mild cognitive impairment
 
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docxRunning Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
 
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docxRunning Head PICOT1PICOT4Comment by Crystal Bowm.docx
Running Head PICOT1PICOT4Comment by Crystal Bowm.docx
 
Relationship Between Obesity Diabetes PICOT Essay.pdf
Relationship Between Obesity Diabetes PICOT Essay.pdfRelationship Between Obesity Diabetes PICOT Essay.pdf
Relationship Between Obesity Diabetes PICOT Essay.pdf
 
Novel Approach Of Diabetes Disease Classification By Support Vector Machine W...
Novel Approach Of Diabetes Disease Classification By Support Vector Machine W...Novel Approach Of Diabetes Disease Classification By Support Vector Machine W...
Novel Approach Of Diabetes Disease Classification By Support Vector Machine W...
 
Anticholinergic Drugs And Risk Of Dementia Case-Control Study
Anticholinergic Drugs And Risk Of Dementia  Case-Control StudyAnticholinergic Drugs And Risk Of Dementia  Case-Control Study
Anticholinergic Drugs And Risk Of Dementia Case-Control Study
 
PREVALENCE OF DEPRESSION AND ITS ASSOCIATED FACTORS IN ADULTS WITH DIABETES M...
PREVALENCE OF DEPRESSION AND ITS ASSOCIATED FACTORS IN ADULTS WITH DIABETES M...PREVALENCE OF DEPRESSION AND ITS ASSOCIATED FACTORS IN ADULTS WITH DIABETES M...
PREVALENCE OF DEPRESSION AND ITS ASSOCIATED FACTORS IN ADULTS WITH DIABETES M...
 
Prevalence and Determinants of Distress Among Residents During COVID Crisis
Prevalence and Determinants of Distress Among Residents During COVID CrisisPrevalence and Determinants of Distress Among Residents During COVID Crisis
Prevalence and Determinants of Distress Among Residents During COVID Crisis
 
Prevalence and Determinants of Distress Among Residents During COVID Crisis
Prevalence and Determinants of Distress Among Residents During COVID CrisisPrevalence and Determinants of Distress Among Residents During COVID Crisis
Prevalence and Determinants of Distress Among Residents During COVID Crisis
 
Prevalence and Determinants of Distress Among Residents During COVID Crisis
Prevalence and Determinants of Distress Among Residents During COVID CrisisPrevalence and Determinants of Distress Among Residents During COVID Crisis
Prevalence and Determinants of Distress Among Residents During COVID Crisis
 
Prevalence and determinants of distress among residents during COVID crisis
Prevalence and determinants of distress among residents during COVID crisisPrevalence and determinants of distress among residents during COVID crisis
Prevalence and determinants of distress among residents during COVID crisis
 
Annals of Clinical and Medical Case Reports - Acmcasereport
Annals of Clinical and Medical Case Reports - AcmcasereportAnnals of Clinical and Medical Case Reports - Acmcasereport
Annals of Clinical and Medical Case Reports - Acmcasereport
 
Medical research methodology
Medical research methodologyMedical research methodology
Medical research methodology
 
TYPE 2 DIABETES TYPE 2 DIABETES .docx
TYPE 2 DIABETES TYPE 2 DIABETES                               .docxTYPE 2 DIABETES TYPE 2 DIABETES                               .docx
TYPE 2 DIABETES TYPE 2 DIABETES .docx
 
Articulo 1
Articulo 1Articulo 1
Articulo 1
 
BMJ Open-2016-Kandelaki-(1)
BMJ Open-2016-Kandelaki-(1)BMJ Open-2016-Kandelaki-(1)
BMJ Open-2016-Kandelaki-(1)
 
Naheed
NaheedNaheed
Naheed
 
Ebpppt
EbppptEbpppt
Ebpppt
 

Último

Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Último (20)

Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 

Crp critical appraisal group 9 cohort

  • 2. Group 9  Puveraj Gunasekaran 130110132026  Nor Adira Eliany Binti Alias 130110113053  Michelle Ann Sheridan Daniel 130110132017  Visalakshi Ramanathan 130110132042  Muhammad Ikhlas Abdian Putra 130110130126  Raka Ghufran Wibowo 130110130170  Ahsani Rahma Rudibianti 130110130073  Muhammad Nuur Fauzi 130110130049  Renita Dewi Supiyana 130110130115  Amalia Ahsani 130110130061  Evi Anugrah Arumningsih 130110130074  Fatimah Amalia 130110130140  Nabila Nauli Asriputri 130110130155  Jasmine Maulinda Utami 130110130195
  • 3. Answerable question based on the scenario above according to PICO scheme.  Patient or problem : 60-year old female newly diagnosed with peripheral arterial disease  Intervention : type 2 diabetes  Comparison : -  Outcome : peripheral arterial disease.
  • 4. Critical Appraisal based on Tool Kit 1. Did the study address a clearly focused issue?  Yes, The population studied were clearly described and the risk factors were also mentioned. Besides that, the outcomes were considered in two ways where there was a primary outcome and a secondary outcome. It’s clear that the study tried to detect a beneficial effect.
  • 5. Critical Appraisal based on Tool Kit 2. Did the authors use an appropriate method to answer their question?  Is a cohort study a good way of answering the question under the circumstances? Yes  Did it address the study question? We have addressed these gaps in knowledge by establishing a large prospective cohort using linked electronic health records,8,9 which combine information about diabetes diagnosis, risk factors, and medication use with future cardiovascular events. Our objective was to investigate and compare associations between type 2 diabetes and future risk of 12 of the most common initial cardiovascular presentations in men and women.
  • 6. Critical Appraisal based on Tool Kit 3. Were the cohort recruited in an acceptable way?  No, because not all subjects are classified into expose group using the same procedure this study used multivariable cox regression they also used multiple imputation to account missing covariate data
  • 7. Critical Appraisal based on Tool Kit 4. Was the exposure accurately measured to minimize bias? Yes HINT: We are looking for measurement or classification bias: - Did they use subjective or objective measurements? Objective. We defined individuals as having diabetes at baseline (type 1, type 2, or uncertain type) on the basis of coded diagnoses recorded in CPRD or hospital episode statistics at or before study entry (appendix). - Do the measures truly reflect what you want them to (have they been validated)? : Cant tell. - Were all the subjects classified into exposure groups using the same procedure? : Yes We defined individuals as having diabetes at baseline (type 1, type 2, or uncertain type) on the basis of coded diagnoses recorded in CPRD or hospital episode statistics at or before study entry (appendix).
  • 8. Critical Appraisal based on Tool Kit5. Was the outcome accurately measured to minimize bias?  Yes - Did they use subjective or objective measurements? objective measurement - Do the measures truly reflect what you want them to (have they been validated)? they have been validated - Has a reliable system been established for detecting all the cases (for measuring disease occurrence)? reliable system has been established for detecting all the case - Were the measurement methods similar in the different groups? measurement were similar in different group - Were the subjects and/or the outcome assessor blinded to exposure (does this matter)? no blinded to exposure
  • 9. Critical Appraisal based on Tool Kit 6. A. Have the authors identified all important confounding factors? Yes List the ones you think might be important, that the authors missed. B. Have they taken account of the confounding factors in the design and/or analysis? Yes  Modeling : Social deprivation was included in models as quintiles of the index of multiple deprivation, a score calculated for each participant’s neighbourhood on the basis of social indices such as income, education, and employment  Stratified : Data recorded before study entry were used to classify participants as never smokers, ex-smokers, or current smokers at baseline. The baseline hazard function of each model was stratifi ed by general practice and sex, and we used multiple imputation to account for missing covariate data (appendix). We also did analyses adjusted for age and sex only, and analyses adjusted for age, sex, and cardiovascular risk factors. We assessed interactions with age and sex.
  • 10. Critical Appraisal based on Tool Kit  Regression : We used multivariable Cox regression to calculate cause- specific hazards for associations between type 2 diabetes and initial presentations of cardiovascular disease.  Sensitivity : We did a sensitivity analysis comparing individuals with any diabetes diagnosis to those without diabetes (most patients with diabetes in a cohort of this age would have type 2 diabetes). We did sensitivity analyses ignoring endpoints recorded only in primary care (CPRD), restricted to fatal endpoints, or restricted to individuals who entered the study after 2004. We did analyses using R 2.15. This trial is registered with ClinicalTrials.gov, number NCT01804439.
  • 11. Critical Appraisal based on Tool Kit 7. A. Was the follow up of subjects complete enough? Yes B. Was the follow up of subjects long enough? Yes Because the long of the interval is 5,5 years
  • 12. Critical Appraisal based on Tool Kit 8. What are the results of this study? -This study includes 1921260 individuals whereby 1887062 did not have diabetes and 34198 had DM Type 2. -There were 113638 cardiovascular events over 11.6million person-years of follow up. -6137 were DM Type 2 individuals, where 992 individual with peripheral arterial disease and 866 individual with heart failure was the first presentation. -107501 were individual without DM Type 2, where 10074 with peripheral arterial disease and 13072 individual with heart failure was the first presentation.
  • 13. Critical Appraisal based on Tool Kit -For individual aged 40 years without cardiovascular disease, risk of getting CD by 80years old :- -No other statistically significant differences between sexes. -In DM Type2 individual, risk of cardiovascular disease was highest for those with HbA1c concentration of 58 mmol/mol or higher. -Individual with DM Type2 and HbA1c concentration less than 48mmol/mol had an increased risk of peripheral arterial disease and ischaemic stroke, but no greater risk of any of the other 12 cardiovascular diseases.
  • 14. Critical Appraisal based on Tool Kit 9. How precise are the results?  How precise is the estimate of the risk? By looking at the value of confidence interval HINT: - Size of the confidence intervals The prevalence of any type of diabetes in all individuals in CALIBER aged 40–50 years (with or without previous cardiovascular disease) was 1·52% (95% CI 1·47–1·57) in women and 2·25% (2·19–2·32) in men (appendix).
  • 15. Critical Appraisal based on Tool Kit 10. Do you believe the results?  HINT: -Big effect is hard to ignore! (???) -Can it be due to bias, chance or confounding? No -Are the design and methods of this study sufficiently flawed to make the results unreliable? No. This study used records from the CALIBER programme, which links data for people in England recorded in four electronic health data sources. They define individuals as having diabetes using CPRD record and also check the HbA measurements for diabetic patients. And also they use cumulative incidence curves for comparing the initial presentation of cardiovascular disease and used Cox models to estimate cause-specific hazard ratios. And overall, the result were robust to a range of modifications explored in sensitivity analyses, which is type 2 diabetes was strongly associated with composite cardiovascular mortality and all-cause mortality. -Consider Bradford-Hills criteria!
  • 16. Critical Appraisal based on Tool Kit  11. Can the results be applied to the local population? YES  HINT: consider whether: 1. the subjects covered in the study could be sufficiently different from your population to cause concern 2. your local setting is likely to differ much from that of the study 3. can you quantify local benefit and harm? benefit: because this research take subjects from wide range of population in UK, obviously it can represent local population there. so, the benefit for local people are they can prevent cardiovascular disease if they have DM type 2 harm: wide range of cardiovascular disease that might occur could confusing us, it could lead us to wrong preventive action with harmful effect.
  • 17. Critical Appraisal based on Tool Kit  12. Do the results of this study fit with other available evidence? Yes